Responder Analyses for Patient-Reported Outcomes in a Pooled Analysis of Two Phase III Randomized Placebo Controlled Trials of Gefapixant, a P2X3 Receptor Antagonist for the Treatment of Chronic Cough

S.S. Birring; A.H. Morice; J. Smith; L. McGarvey; I.D. Pavord; A. Martin Nguyen; J. Schelfhout; P. Dicpinigaitis; B. Iskold; A. Tzontcheva; Q. Li; D. Muccino; C. La Rosa

doi:10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2354

Responder Analyses for Patient-Reported Outcomes in a Pooled Analysis of Two Phase III Randomized Placebo Controlled Trials of Gefapixant, a P2X3 Receptor Antagonist for the Treatment of Chronic Cough

S.S. Birring, A.H. Morice, J. Smith, L. McGarvey, I.D. Pavord, A. Martin Nguyen, J. Schelfhout, P. Dicpinigaitis, B. Iskold, A. Tzontcheva, Q. Li, D. Muccino, C. La Rosa

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Journal	TP44. TP044 ASSESSMENT AND TREATMENT OF COUGH AND CHRONIC DYSPNEA
DOIs	https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2354
Publication status	Early online date - 03 May 2021

Access to Document

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2354Licence: Unspecified

Cite this

Birring, S. S., Morice, A. H., Smith, J., McGarvey, L., Pavord, I. D., Martin Nguyen, A., Schelfhout, J., Dicpinigaitis, P., Iskold, B., Tzontcheva, A., Li, Q., Muccino, D., & La Rosa, C. (2021). Responder Analyses for Patient-Reported Outcomes in a Pooled Analysis of Two Phase III Randomized Placebo Controlled Trials of Gefapixant, a P2X3 Receptor Antagonist for the Treatment of Chronic Cough. TP44. TP044 ASSESSMENT AND TREATMENT OF COUGH AND CHRONIC DYSPNEA. Advance online publication. https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2354

@article{265d90b76bf645d786cebd89e0a56e33,

title = "Responder Analyses for Patient-Reported Outcomes in a Pooled Analysis of Two Phase III Randomized Placebo Controlled Trials of Gefapixant, a P2X3 Receptor Antagonist for the Treatment of Chronic Cough",

author = "S.S. Birring and A.H. Morice and J. Smith and L. McGarvey and I.D. Pavord and {Martin Nguyen}, A. and J. Schelfhout and P. Dicpinigaitis and B. Iskold and A. Tzontcheva and Q. Li and D. Muccino and {La Rosa}, C.",

year = "2021",

month = may,

day = "3",

doi = "10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2354",

language = "English",

journal = "TP44. TP044 ASSESSMENT AND TREATMENT OF COUGH AND CHRONIC DYSPNEA",

publisher = "American Thoracic Society",

}

Birring, SS, Morice, AH, Smith, J, McGarvey, L, Pavord, ID, Martin Nguyen, A, Schelfhout, J, Dicpinigaitis, P, Iskold, B, Tzontcheva, A, Li, Q, Muccino, D & La Rosa, C 2021, 'Responder Analyses for Patient-Reported Outcomes in a Pooled Analysis of Two Phase III Randomized Placebo Controlled Trials of Gefapixant, a P2X3 Receptor Antagonist for the Treatment of Chronic Cough', TP44. TP044 ASSESSMENT AND TREATMENT OF COUGH AND CHRONIC DYSPNEA. https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2354

Responder Analyses for Patient-Reported Outcomes in a Pooled Analysis of Two Phase III Randomized Placebo Controlled Trials of Gefapixant, a P2X3 Receptor Antagonist for the Treatment of Chronic Cough. / Birring, S.S.; Morice, A.H.; Smith, J. et al.
In: TP44. TP044 ASSESSMENT AND TREATMENT OF COUGH AND CHRONIC DYSPNEA, 03.05.2021.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Responder Analyses for Patient-Reported Outcomes in a Pooled Analysis of Two Phase III Randomized Placebo Controlled Trials of Gefapixant, a P2X3 Receptor Antagonist for the Treatment of Chronic Cough

AU - Birring, S.S.

AU - Morice, A.H.

AU - Smith, J.

AU - McGarvey, L.

AU - Pavord, I.D.

AU - Martin Nguyen, A.

AU - Schelfhout, J.

AU - Dicpinigaitis, P.

AU - Iskold, B.

AU - Tzontcheva, A.

AU - Li, Q.

AU - Muccino, D.

AU - La Rosa, C.

PY - 2021/5/3

Y1 - 2021/5/3

U2 - 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2354

DO - 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2354

M3 - Meeting abstract

JO - TP44. TP044 ASSESSMENT AND TREATMENT OF COUGH AND CHRONIC DYSPNEA

JF - TP44. TP044 ASSESSMENT AND TREATMENT OF COUGH AND CHRONIC DYSPNEA

ER -

Birring SS, Morice AH, Smith J, McGarvey L, Pavord ID, Martin Nguyen A et al. Responder Analyses for Patient-Reported Outcomes in a Pooled Analysis of Two Phase III Randomized Placebo Controlled Trials of Gefapixant, a P2X3 Receptor Antagonist for the Treatment of Chronic Cough. TP44. TP044 ASSESSMENT AND TREATMENT OF COUGH AND CHRONIC DYSPNEA. 2021 May 3. Epub 2021 May 3. doi: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2354